SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Anuh Pharma informs about closure of trading window

24 Jun 2024 Evaluate
Anuh Pharma has informed that pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 read with BSE circular No. LIST/COMP/01/2019-20 dated 02nd April, 2019, the Trading window for dealing in the securities of Anuh Pharma shall remain closed for all the insiders/designated persons and their immediate relatives, from Monday, July 01, 2024 till the expiry of 48 hours after the declaration of Unaudited Financial Results for the quarter ended June 30, 2024. Accordingly, all the insiders/designated persons and their immediate relatives as per the Code are advised not to deal in the securities of the Company during the aforesaid period of Closure of Trading Window.

The above information is a part of company’s filings submitted to BSE.

Anuh Pharma Share Price

82.80 0.08 (0.10%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×